Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy

Abstract

The findings of this study suggest that the addition of acarbose to sulphonylurea/insulin combination therapy can improve glycaemic control in type 2 diabetic patients. Acarbose may also reduce insulin resistance and hyperinsulinaemia.